Lake Erie College of Osteopathic Medicine (LECOM) is reinforcing its commitment to accessible and affordable pharmacy ...

April 14, 2026 - PRESSADVANTAGE - All Pro Gutter Guards has announced the expansion of its service line to include ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...

The success of the Women’s Health Strategy will depend on whether innovation can be adopted at scale, writes Dr MaryAnn Ferreux ...

A first-in-human clinical trial evaluating an investigational gene therapy targeting complement-mediated pathways in ...

Washington: The researchers at the University of Chicago have uncovered a surprising new role for zeaxanthin, a plant-based ...

Immunoglobulin A (IgA) nephropathy results from the accumulation of IgA-containing immune complexes (IgA-ICs) and aberrant ...

InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced new in vitro findings demonstrating that izicopan ...

Microbial infections, caused by bacteria, viruses, and parasites, pose a significant challenge to global health, affecting millions annually. Despite advancements in medical science, understanding the ...

Odd chemical pathways can give completely unexpected makeovers to some of the most troublesome waste; take, for example, an ...

"Health systems already have dedicated teams working hard to prevent readmissions," said Brad Prugh, CEO of Care Continuity. ...

Since the World Trade Organisation (WTO)’s creation in 1995, the globalised trading system has driven the world’s economic ...